Correlation Between Tonix Pharmaceuticals and RESAAS Services

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and RESAAS Services at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and RESAAS Services into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and RESAAS Services, you can compare the effects of market volatilities on Tonix Pharmaceuticals and RESAAS Services and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of RESAAS Services. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and RESAAS Services.

Diversification Opportunities for Tonix Pharmaceuticals and RESAAS Services

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tonix and RESAAS is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and RESAAS Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RESAAS Services and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with RESAAS Services. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RESAAS Services has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and RESAAS Services go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and RESAAS Services

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the RESAAS Services. In addition to that, Tonix Pharmaceuticals is 1.32 times more volatile than RESAAS Services. It trades about -0.08 of its total potential returns per unit of risk. RESAAS Services is currently generating about 0.03 per unit of volatility. If you would invest  20.00  in RESAAS Services on November 2, 2024 and sell it today you would lose (4.00) from holding RESAAS Services or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  RESAAS Services

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
RESAAS Services 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RESAAS Services has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Tonix Pharmaceuticals and RESAAS Services Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and RESAAS Services

The main advantage of trading using opposite Tonix Pharmaceuticals and RESAAS Services positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, RESAAS Services can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RESAAS Services will offset losses from the drop in RESAAS Services' long position.
The idea behind Tonix Pharmaceuticals Holding and RESAAS Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios